MediPress Health-Limited Partnership
MediPress Health-Limited Partnership
Share · IL0011828980 (XTAE)
Overview
No Price
Closing Price XTAE 28.10.2025: 62,00 ILA
28.10.2025 08:43
Current Prices from MediPress Health-Limited Partnership
ExchangeTickerCurrencyLast TradePriceDaily Change
XTAE: TASE
TASE
MPRS.TA
ILA
28.10.2025 08:43
62,00 ILA
1,10 ILA
+1,81 %
Company Profile for MediPress Health-Limited Partnership Share
MediPress Health-Limited Partnership, is a research and development life science partnership and venture capital firm specializing in seed/startups investments. The firm seeks to invest in medical research and development companies. Its portfolio companies engage in the treatment of cancer with proton radiation therapy; and the development of non-surgical vaginal solutions for women with various pelvic floor disorders. The firm seeks to take board positions in its portfolio companies. MediPress Health-Limited Partnership was incorporated in 2021 and is based in Ramat Gan, Israel.
Get up to date insights from finAgent about MediPress Health-Limited Partnership

Company Data

Name MediPress Health-Limited Partnership
Company MediPress Health-Limited Partnership
Primary Exchange XTAE TASE
ISIN IL0011828980
Asset Class Share
Sector Healthcare
Industry Medical - Devices
CEO Joseph Press
Country Israel
Currency ILA
Employees -
Address 40 Tuval Street, 5252247 Ramat Gan
IPO Date 2021-12-30

Ticker Symbols

Name Symbol
TASE MPRS.TA
More Shares
Investors who hold MediPress Health-Limited Partnership also have the following shares in their portfolio:
CEB 23/26 MTN
CEB 23/26 MTN Bond
U.S. BANCORP 24/30 FLRMTN
U.S. BANCORP 24/30 FLRMTN Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025